Cleared Traditional

K203104 - IBM iConnect Access

K203104 is the FDA 510(k) clearance for IBM iConnect Access by Merge Healthcare Incorporated. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 104-day FDA review.

K203104 · Merge Healthcare Incorporated · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
104d
Days
Class 2
Risk

K203104 is an FDA 510(k) clearance for the IBM iConnect Access. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Merge Healthcare Incorporated (Hartland, US). The FDA issued a Cleared decision on January 26, 2021 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Merge Healthcare Incorporated devices

Submission Details

510(k) Number K203104 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 14, 2020
Decision Date January 26, 2021
Days to Decision 104 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d faster than avg
Panel avg: 107d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1092
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K203104.
Synapse 3D, Synapse 3D Base Tools v6.1
K203103 · Fujifilm Corporation · Feb 2021
Bonelogic
K203290 · Disior, Ltd. · Feb 2021
QUIBIM Precision Prostate (qp-Prostate)
K203582 · Quibim S.L. · Feb 2021
AccuBrain
K202847 · Brainnow Medical Technology Limited · Jan 2021
Veuron-Brain-pAb
K203142 · Heuron Co., Ltd. · Jan 2021
ViewPoint 6
K203677 · GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · Jan 2021